Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review

Malignant mesothelioma is an aggressive cancer with poor prognosis, predominantly caused by human occupational exposure to asbestos. The global incidence of mesothelioma is predicted to increase as a consequence of continued exposure to asbestos from a variety of sources, including construction mate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ben William Johnson, Ken Takahashi, Yuen Yee Cheng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/7a332958de704142a9c469bf2c8201e5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a332958de704142a9c469bf2c8201e5
record_format dspace
spelling oai:doaj.org-article:7a332958de704142a9c469bf2c8201e52021-11-11T07:25:42ZPreclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review2234-943X10.3389/fonc.2021.748444https://doaj.org/article/7a332958de704142a9c469bf2c8201e52021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.748444/fullhttps://doaj.org/toc/2234-943XMalignant mesothelioma is an aggressive cancer with poor prognosis, predominantly caused by human occupational exposure to asbestos. The global incidence of mesothelioma is predicted to increase as a consequence of continued exposure to asbestos from a variety of sources, including construction material produced in the past in developed countries, as well as those currently being produced in developing countries. Mesothelioma typically develops after a long latency period and consequently it is often diagnosed in the clinic at an advanced stage, at which point standard care of treatment, such as chemo- and radio-therapy, are largely ineffective. Much of our current understanding of mesothelioma biology, particularly in relation to disease pathogenesis, diagnosis and treatment, can be attributed to decades of preclinical basic science research. Given the postulated rising incidence in mesothelioma cases and the limitations of current diagnostic and treatment options, continued preclinical research into mesothelioma is urgently needed. The ever-evolving landscape of preclinical models and laboratory technology available to researchers have made it possible to study human disease with greater precision and at an accelerated rate. In this review article we provide an overview of the various resources that can be exploited to facilitate an enhanced understanding of mesothelioma biology and their applications to research aimed to improve the diagnosis and treatment of mesothelioma. These resources include cell lines, animal models, mesothelioma-specific biobanks and modern laboratory techniques/technologies. Given that different preclinical models and laboratory technologies have varying limitations and applications, they must be selected carefully with respect to the intended objectives of the experiments. This review therefore aims to provide a comprehensive overview of the various preclinical models and technologies with respect to their advantages and limitations. Finally, we will detail about a highly valuable preclinical laboratory resource to curate high quality mesothelioma biospecimens for research; the biobank. Collectively, these resources are essential to the continued advancement of precision medicine to curtail the increasing health burden caused by malignant mesothelioma.Ben William JohnsonKen TakahashiYuen Yee ChengFrontiers Media S.A.articlemesotheliomaresearch resourcespreclinical modelsfacilitybiobankNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic mesothelioma
research resources
preclinical models
facility
biobank
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle mesothelioma
research resources
preclinical models
facility
biobank
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ben William Johnson
Ken Takahashi
Yuen Yee Cheng
Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
description Malignant mesothelioma is an aggressive cancer with poor prognosis, predominantly caused by human occupational exposure to asbestos. The global incidence of mesothelioma is predicted to increase as a consequence of continued exposure to asbestos from a variety of sources, including construction material produced in the past in developed countries, as well as those currently being produced in developing countries. Mesothelioma typically develops after a long latency period and consequently it is often diagnosed in the clinic at an advanced stage, at which point standard care of treatment, such as chemo- and radio-therapy, are largely ineffective. Much of our current understanding of mesothelioma biology, particularly in relation to disease pathogenesis, diagnosis and treatment, can be attributed to decades of preclinical basic science research. Given the postulated rising incidence in mesothelioma cases and the limitations of current diagnostic and treatment options, continued preclinical research into mesothelioma is urgently needed. The ever-evolving landscape of preclinical models and laboratory technology available to researchers have made it possible to study human disease with greater precision and at an accelerated rate. In this review article we provide an overview of the various resources that can be exploited to facilitate an enhanced understanding of mesothelioma biology and their applications to research aimed to improve the diagnosis and treatment of mesothelioma. These resources include cell lines, animal models, mesothelioma-specific biobanks and modern laboratory techniques/technologies. Given that different preclinical models and laboratory technologies have varying limitations and applications, they must be selected carefully with respect to the intended objectives of the experiments. This review therefore aims to provide a comprehensive overview of the various preclinical models and technologies with respect to their advantages and limitations. Finally, we will detail about a highly valuable preclinical laboratory resource to curate high quality mesothelioma biospecimens for research; the biobank. Collectively, these resources are essential to the continued advancement of precision medicine to curtail the increasing health burden caused by malignant mesothelioma.
format article
author Ben William Johnson
Ken Takahashi
Yuen Yee Cheng
author_facet Ben William Johnson
Ken Takahashi
Yuen Yee Cheng
author_sort Ben William Johnson
title Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
title_short Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
title_full Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
title_fullStr Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
title_full_unstemmed Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
title_sort preclinical models and resources to facilitate basic science research on malignant mesothelioma – a review
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/7a332958de704142a9c469bf2c8201e5
work_keys_str_mv AT benwilliamjohnson preclinicalmodelsandresourcestofacilitatebasicscienceresearchonmalignantmesotheliomaareview
AT kentakahashi preclinicalmodelsandresourcestofacilitatebasicscienceresearchonmalignantmesotheliomaareview
AT yuenyeecheng preclinicalmodelsandresourcestofacilitatebasicscienceresearchonmalignantmesotheliomaareview
_version_ 1718439411864043520